Skip to main content
Clinical Trials/JPRN-UMIN000044955
JPRN-UMIN000044955
Recruiting
未知

A multicentre, retrospective study in patients with multiple sclerosis treated with natalizumab in real-world setting in Japan - REFIND Study

Tohoku Medical and Pharmaceutical University0 sites150 target enrollmentJuly 26, 2021

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
Tohoku Medical and Pharmaceutical University
Enrollment
150
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
July 26, 2021
End Date
April 30, 2022
Last Updated
2 years ago
Study Type
Observational
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Patients who are deemed inappropriate for participation in this study by the principal investigator or sub\-investigator.

Outcomes

Primary Outcomes

Not specified

Similar Trials